Cargando…

High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)

BACKGROUND: Patients with stable coronary artery disease on single-antiplatelet therapy with aspirin are still at risk for atherothrombotic events, and high on-aspirin residual platelet reactivity (RPR) has been suggested as a risk factor. METHODS AND RESULTS: In this randomized trial, the associati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pettersen, Alf-Åge R., Seljeflot, Ingebjørg, Abdelnoor, Michael, Arnesen, Harald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487336/ https://www.ncbi.nlm.nih.gov/pubmed/23130135 http://dx.doi.org/10.1161/JAHA.112.000703

Ejemplares similares

vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
por: Warlo, Ellen M. K., et al.
Publicado: (2017)

Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment
por: Bratseth, Vibeke, et al.
Publicado: (2012)

The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel
por: Pettersen, Alf-Aage R, et al.
Publicado: (2011)

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
por: Sharma, Rakesh K, et al.
Publicado: (2009)

Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes
por: Opstad, Trine B, et al.
Publicado: (2010)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
por: Kuliczkowski, Wiktor, et al.
Publicado: (2021)

TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients—A Possible Link to Clonal Hematopoiesis
por: Opstad, Trine B., et al.
Publicado: (2022)

The MMP-9 -1562 C/T Polymorphism in the Presence of Metabolic Syndrome Increases the Risk of Clinical Events in Patients with Coronary Artery Disease
por: Opstad, Trine B., et al.
Publicado: (2014)

The Co-Existence of the IL-18+183 A/G and MMP-9 -1562 C/T Polymorphisms Is Associated with Clinical Events in Coronary Artery Disease Patients
por: Opstad, Trine B., et al.
Publicado: (2013)

Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an Observational Study
por: Opstad, Trine B, et al.
Publicado: (2011)

Aspirin and Clopidogrel Resistance
por: Sztriha, Laszlo K., et al.
Publicado: (2004)

Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial
por: Wang, Yilong, et al.
Publicado: (2019)

Complement Activation in Association with Markers of Neutrophil Extracellular Traps and Acute Myocardial Infarction in Stable Coronary Artery Disease
por: Kluge, Karsten E., et al.
Publicado: (2020)

Inability to Reverse Aspirin and Clopidogrel-induced Platelet Dysfunction with Platelet Infusion
por: Cohn, Stephen M, et al.
Publicado: (2019)

Measurement of Platelet Function in an Experimental Stroke Model With Aspirin and Clopidogrel Treatment
por: Lieschke, Franziska, et al.
Publicado: (2020)

Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel
por: Puccini, Marianna, et al.
Publicado: (2022)

Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events
por: Warlo, Ellen M. K., et al.
Publicado: (2022)

A Combination of Aspirin and Clopidogrel Predict More Favorable Dynamics of Platelet Reactivity versus Clopidogrel Alone in the Acute Phase of Minor Stroke
por: Wiśniewski, Adam, et al.
Publicado: (2021)

Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis
por: Tan, Shuai, et al.
Publicado: (2015)

Comparison of Triple Anti-Platelet Therapy (Aspirin, Clopidogrel, and Cilostazol) and Double Anti-Platelet Therapy (Aspirin and Clopidogrel) on Platelet Aggregation in Type 2 Diabetic Patients Undergoing Drug-Eluting Stent Implantation
por: Yang, Tae-Hyun, et al.
Publicado: (2009)

The ascetic imperative in culture and criticism
por: Harpham, Geoffrey Galt, 1946-
Publicado: (1987)

Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel
por: Cirillo, Plinio, et al.
Publicado: (2020)

Effects of Cilostazol on Platelet Activation in Coronary Stenting Patients Who Already Treated with Aspirin and Clopidogrel.
por: Ahn, Jeong Cheon, et al.
Publicado: (2004)

Aspirin and clopidogrel resistance: methodological challenges and opportunities
por: Gasparyan, Armen Yuri
Publicado: (2010)

Aspirin/clopidogrel: Lack of efficacy: case report
Publicado: (2020)

Influence of Sex on Platelet Reactivity in Response to Aspirin
por: Friede, Kevin A., et al.
Publicado: (2020)

Evaluation of Aspirin and Clopidogrel resistance in patients with Acute Coronary Syndrome by using Adenosine Diposphate Test and Aspirin Test
por: O, Ibrahim, et al.
Publicado: (2013)

Impact of Aspirin and Clopidogrel Interruption on Platelet Function in Patients Undergoing Major Vascular Surgery
por: Le Manach, Yannick, et al.
Publicado: (2014)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
por: Neubauer, Horst, et al.
Publicado: (2011)

Platelet aggregometry testing during aspirin or clopidogrel treatment and measurement of clopidogrel metabolite concentrations in dogs with protein‐losing nephropathy
por: Shropshire, Sarah, et al.
Publicado: (2020)

The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
por: Kulik, Alexander, et al.
Publicado: (2005)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)

Analysis of the Reactivity of Aspirin and Clopidogrel and Its Influencing Factors in Patients with Coronary Heart Disease at High Altitude
por: Chang, Rong, et al.
Publicado: (2021)

Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
por: Algra, Ale, et al.
Publicado: (2000)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
por: Hemlata,, et al.
Publicado: (2013)

Comparative effect of clopidogrel plus aspirin and aspirin monotherapy on hematological parameters using propensity score matching
por: Hayasaka, Masatoshi, et al.
Publicado: (2013)

Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study
por: Lee, Meng, et al.
Publicado: (2014)

Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke
por: Pan, Yuesong, et al.
Publicado: (2014)

Comparison of Multiplate, Platelet Function Analyzer‐200, and Plateletworks in Healthy Dogs Treated with Aspirin and Clopidogrel
por: Saati, S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9pfe2mtbg7beu67876gurb33mr